InternationalUSRemember you can easily switch between MIP US and MIP International at any time

MIP PTAB Forum 2018

May 3, Convene 810 Seventh, New York
May 8, Sheraton, Palo Alto

Agenda - New York

Download the New York brochure here 

9:00 Registration

9:30 Opening remarks by Michael Loney, managing editor, Managing IP

9:40 State of play and progression at the Patent Trial and
Appeal Board

  • Overview of institutional changes of AIA
  • Exploring the success in driving settlements
  • Asymmetry between patent owner, challenger and petitioner: the call for consistency

Jeremiah Frueauf, director, Sterne Kessler Goldstein & Fox
Janet Gongola, vice chief judge, Patent Trial and Appeal Board
Anna Volftsun, associate counsel, Humanscale
Rich Coller,
director, Sterne Kessler Goldstein & Fox

10:30 Coffee break and networking

11:00 Strategies for litigating in the changing PTAB environment

  • Update on recent PTAB developments (e.g., Wi-Fi One v Broadcom)
  • Strategies for capitalizing on recent developments
  • PTAB trends to watch

Jason Stach, partner, Finnegan Henderson Farabow Garrett & Dunner
Melissa Brand
, director of intellectual property policy, Biotechnology Innovation Organisation
Srikala Atluri, IP litigation counsel, Hewlett Packard Enterprise
Trenton Ward,
partner, Finnegan Henderson Farabow Garrett & Dunner

11:50 Evolving procedural challenges associated with AIA

  • Updates from PTAB rules of practice
  • Supreme Court’s question of constitutionality: Oil states
  • Motions to amend in PTAB proceedings – Aqua products
  • Adapting to the rule changes and managing your strategy for next six to 12 months

Scott McKeown, partner, Ropes & Gray (moderator)
Ashraf Fawzy, senior patent counsel, Unified Patents
Thomas Giannetti, administrative patent judge, Patent Trial and Appeal Board

12:40 Lunch and networking

13:30 Latest Federal Circuit developments

  • Understanding what types of errors by the PTAB are most likely to be reversed by the Federal Circuit
  • What types of errors by the CAFC Panel are most likely to be reconsidered en banc
  • What types of errors are most likely to get SCOTUS interest

Charles Macedo, partner, Amster Rothstein & Ebenstein
Kristan Lansbery,
director, patent attorney, Regeneron Pharmaceuticals

14:20 PTAB by the numbers; data, trends & analysis

  • Comparative analysis: when to choose IPR versus PGR versus CBM
  • Success rates at PTAB: assessing the growing demand & what is working well
  • Review of statistics on IPRS both PTAB & Federal Circuit
  • EPO opposition versus PTAB

Justin Oliver, partner, Fitzpatrick Cella Harper & Scinto (moderator)
Albert Keyack, IP attaché, European Patent Office
Joshua Landau, patent counsel, Computer & Communications Industry Association
Kim McGraw
, administrative patent judge, Patent Trial and Appeal Board
Jason Dorsky
, senior associate, Fitzpatrick Cella Harper & Scinto

15:10 Coffee break and networking

15:30 Interplay between PTAB, District Court litigation and ITC

  • To what extend does claim construction at PTAB impact district court & ITC proceedings?
  • Uncertainty and challenges surrounding validity and infringement
  • Effective obviousness rationales at the District Court and PTAB
  • Will there be more ITC actions?

Natalie Clayton, partner, Alston Bird (moderator)
Chloe Jiang, senior attorney, Novo Nordisk
Larry Coury, director dispute resolution, Regeneron Pharmaceuticals
Monisha Deka, investigative attorney, International Trade Commission
Chris Douglas, partner, Alston Bird

16:20 Developments and considerations for life sciences IPRs

  • IPR challenges to drug patent claim types and success rates so far
  • Dramatic rise of biosimilar IPR filing: is this set to continue?
  • Interplay with IPR proceedings and District Court litigation

Corinne Atton, senior associate, Fitzpatrick Cella Harper & Scinto (moderator)
Leon Lum, intellectual property counsel, Novo Nordisk
Serge Ilin-Schneider
, director, intellectual property, Par Pharmaceutical

17:10 Close of conference





More from the Managing IP blog

null null null

null null null

November / December 2019

IP law: are the pressures taking their toll?

Following World Mental Health Day, Max Walters seeks the views of in-house professionals on whether they struggle with workplace pressures, and asks how to improve wellbeing

Most read articles